FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3867511000001100: Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21757701000001113 Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21757801000001116 Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Is pack of Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories false Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has active ingredient Zinc oxide false Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has VMP Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories true Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has specific active ingredient Zinc oxide true Inferred relationship Existential restriction modifier
Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Germoloids suppositories (Bayer Plc) 12 suppository Is a True Zinc oxide 283.5mg / Lidocaine 13.2mg suppositories 12 suppository Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start